Video

Q&A with Jagpreet Chhatwal, PhD, from Massachusetts General Hospital: Measuring Costs for Hepatitis C Treatment

Author(s):

With more treatments on the market for hepatitis C, the costs of treatment have actually gone up in recent years. However, if more patients receive the care they need those costs could eventually go down.

With more treatments on the market for hepatitis C, the costs of treatment have actually gone up in recent years. However, if more patients receive the care they need those costs could eventually go down.

Jagpreet Chhatwal, PhD, from Massachusetts General Hospital, discussed recent research on the topic during the 2015 Liver Meeting in San Francisco. As part of the study, the researchers looked at the costs of treating those patients currently diagnosed with hepatitis C as well as what it would cost to make the condition a rare disease in the future.

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
Malin Fromme, MD | Credit: RWTH Aachen
Pavel Strnad, MD | Credit: AASLD
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Gideon Hirschfield, FRCP, PhD | Credit: UHN Foundation
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
Country-Level Socioeconomic Status, Healthcare Impact AKI Outcomes in Cirrhosis
© 2024 MJH Life Sciences

All rights reserved.